Since the first semaglutide drug was approved in 2005, patients and manufacturers have seen many changes: shortages, compounding, and more than a thousand lawsuits from patients who experienced severe side effects under these drugs, including stomach paralysis, bowel obstruction, and vision loss
Making the Right Choice for Your Research Protocol So how do you choose
Sanofi, which will market Lyxumia, has announced that it will be available in Germany and the UK in the early months of 2013
Kentucky State was formed during segregation when African-Americans could not attend predominately white institutions, Rep
The result is positive feedback loops: better cellular health improves your body's ability to handle environmental stressors while reducing inflammatory responses